Tatva Chintan Pharma Chem Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 108.94 | 84.04 | 81.77 |
| Operating Expense | 99.75 | 78.35 | 76.36 |
| Net Profit | 1.10 | -1.17 | -1.11 |
| Net Profit Margin | 1.01 | -1.39 | -1.36 |
| Earning Per Share | 0.47 | -0.50 | -0.47 |
| EBIDTA | 8.74 | 6.11 | 5.58 |
| Effective Tax Rate | -0.11 | -1.05 | -5.36 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 108.94 |
| Operating Expense | 99.75 |
| Net Profit | 1.10 |
| Net Profit Margin | 1.01 |
| Earning Per Share | 0.47 |
| EBIDTA | 8.74 |
| Effective Tax Rate | -0.11 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 378.68 | 403.04 | 427.81 |
| Operating Expenses Annual | 311.81 | 348.37 | 322.04 |
| Operating Profit Annual | 74.37 | 56.77 | 116.40 |
| Interest Annual | 6.51 | 8.38 | 4.95 |
| Depreciation | 25.15 | 9.16 | 7.84 |
| Net Profit Annual | 29.35 | 40.47 | 95.99 |
| Tax Annual | 12.92 | -1.63 | 7.28 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 378.68 |
| Operating Expenses Annual | 311.81 |
| Operating Profit Annual | 74.37 |
| Interest Annual | 6.51 |
| Depreciation | 25.15 |
| Net Profit Annual | 29.35 |
| Tax Annual | 12.92 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 21.19 | 60.78 | 2.73 |
| Cash Flow from Operations | 102.78 | 23.73 | 19.76 |
| Cash Flow from Investing | -120.52 | -101.13 | -196.72 |
| Cash Flow from Financing | 30.54 | 37.82 | 235.01 |
| Cash Flow at the End | 33.99 | 21.19 | 60.78 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 21.19 |
| Cash Flow from Operations | 102.78 |
| Cash Flow from Investing | -120.52 |
| Cash Flow from Financing | 30.54 |
| Cash Flow at the End | 33.99 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 19.68 | 14.12 | 27.26 |
| PBIT Margin (%) | 12.92 | 11.75 | 25.35 |
| PBT Margin (%) | 10.98 | 10.37 | 20.46 |
| Net PROFIT Margin (%) | 7.75 | 10.04 | 22.44 |
| Return On Networth / Equity (%) | 4.77 | 8.31 | 30.43 |
| Return On Networth /Employed (%) | 6.90 | 7.48 | 25.71 |
| Return On Assets (%) | 4.11 | 6.43 | 22.66 |
| Total Debt / Equity (X) | 0.15 | 0.30 | 0.33 |
| Asset Turnover Ratio (%) | 0.53 | 0.64 | 1.01 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 19.68 |
| PBIT Margin (%) | 12.92 |
| PBT Margin (%) | 10.98 |
| Net PROFIT Margin (%) | 7.75 |
| Return On Networth / Equity (%) | 4.77 |
| Return On Networth /Employed (%) | 6.90 |
| Return On Assets (%) | 4.11 |
| Total Debt / Equity (X) | 0.15 |
| Asset Turnover Ratio (%) | 0.53 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 430.48 | 196.22 | 159.61 |
| Total Current Assets Annual | 293.61 | 307.61 | 453.12 |
| Non Current Assets Annual | 521.46 | 447.25 | 223.08 |
| Total Shareholders Funds Annual | 725.88 | 504.78 | 468.88 |
| Total Assets Annual | 815.07 | 754.86 | 676.20 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 430.48 |
| Total Current Assets Annual | 293.61 |
| Non Current Assets Annual | 521.46 |
| Total Shareholders Funds Annual | 725.88 |
| Total Assets Annual | 815.07 |
EPS (INR)
Expected
0.44
Reported
0.44
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
